Debiopharm Innovation Fund
Corporate VCLausanne · Pre-Seed–Late Stage · 18 people tracked
Investment thesis
As Debiopharm's corporate venture arm, the fund backs digital health and health tech startups working to transform pharmaceutical R&D and cancer care. Beyond capital, it offers portfolio companies strategic guidance, deepened market knowledge, pharma expertise, and access to Debiopharm's network, positioning itself as a launchpad for scalable, investment-ready companies aiming to improve outcomes for patients globally.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & curated & public directories
What they invest in
from 15 of 17 portfolio companiesAI & Machine Learning ×11Medical Devices ×11Biotech ×9Healthtech ×8Digital Health ×7SaaS ×4Data & Infrastructure ×2Deep Tech ×2
HQs:United States×3Germany×2France×2Belgium×1Canada×1Switzerland×1
Investments · 17 tracked
founders shown can be your intro path
MedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways.
Digital HealthHealthtechMedical DevicesSaaSSilicon Valley, US
Brian Irwin(Chief Executive Officer)Jeffrey Thibeault(Chief Technology Officer)in
Co-investorsNina Capital
Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials.
AI & Machine LearningEnterprise SoftwareMedical Devices
Amit Patel(Founder)inMatt Purri, PhD(Founder)in
Co-investorsEntrepreneurs Roundtable Accelerator (ERA)
Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA
Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)
Co-investorsCreative Destruction Lab (CDL)FusionOrbiMedBenchstrength Partners
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
Co-investorsAngelini VenturesTaiwania CapitalFirst Star VenturesScaleX Venturesredalpine
Co-investorsPKSHA Technology Capital
Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.
AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR
Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)
Co-investorsM VenturesOmnes Capital
Debiopharm is a biopharmaceutical company that develops and manufactures drugs to treat cancer and infectious diseases, and invests in digital health startups.
BiotechDigital HealthMedical DevicesSwitzerland, CH
Rolland-Yves Mauvernay
BoardThierry Mauvernay
ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development.
AI & Machine LearningBiotechMedical Devices
Vedaly provides AI, data analytics, and decision support tools for biopharma companies to integrate insights into scientific and strategic planning.
AI & Machine LearningBiotechData & InfrastructureHealthtechSaaSMartinsried, DE
Tanya Aneichyk(CEO)in
Co-investorsTechstars
Co-investorsAvonmore DevelopmentsCambridge Angels groupDeep Science VenturesOncology Ventures
Raidium develops an AI-native PACS viewer built on a foundation model for radiology, unifying image-viewing and diagnostic tasks in a single promptable platform.
AI & Machine LearningDigital HealthMedical Devices
Paul Herent, M.D., Msc(Founder)in
Co-investorsGalion.exeKurma PartnersNewfund CapitalFounders FutureStartX
Stitch is a platform for clinical research sites that provides participants with a digital interface for their study visits, appointment reminders, and feedback, while reducing administrative workload for study coordinators.
Digital HealthHealthtechSaaSLondon, GB
Mike Sterling(Founder)
Co-investorsBoost Capital PartnersForm VenturesOncology VenturesBenchmarkY Combinator
Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools.
AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US
Anca Copaescu(Founder)Mark Di Ianni(Executive Officer, Director, Promoter)Paulo Carvalho(Executive Officer)inMark Weinstein(Executive Officer, Director)
BoardRob Hess(Director)Vincent Lepreux(Director)in
Co-investorsBand of AngelsHearstLabGolden SeedsOsage Venture Partners
StratifAI develops Polaris, an AI platform that links histology, RNA-seq, and patient outcomes to analyze spatial biology for cancer research.
AI & Machine LearningBiotechMedical DevicesBerlin, DE
Daniel Truhn(Co-Founder & Chief Medical Officer)inFiras Khader(Co-Founder & CTO)inJakob Nikolas Kather(Co-Founder & CSO)inOmar El Nahhas(Co-Founder & CEO)in
Co-investorsPICUS CAPITALAlven
Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data.
CybersecurityData & InfrastructureDeep TechDigital HealthHealthtechBelgium, BE
Co-investorsInflection.xyz
ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology.
AI & Machine LearningBiotechHealthtechMedical Devices
Kenneth To(Chief Executive Officer)Keith Jalbert(Chief Commercial Officer)Christopher Jackson(Chief Scientific Officer)George Hennen(Chief Technology Officer)Rafay Azhar(Medical Director)
Co-investorsSFU VentureLabsSwan Venture FundWittington VenturesWUTIF Capital
Portfolio news
latest coverage across their companiesIktos · techfundingnews.com · Jun 19, 2026
Frequently asked questions
- How many investments has Debiopharm Innovation Fund made?
- Debiopharm Innovation Fund has 17 tracked investments.
- What stage does Debiopharm Innovation Fund invest at?
- Debiopharm Innovation Fund invests at the Pre-Seed, Seed, Series A, Series B, Late Stage stages.
- What is Debiopharm Innovation Fund's typical check size?
- Debiopharm Innovation Fund typically writes checks of $1M – $5M.
- What sectors does Debiopharm Innovation Fund focus on?
- Debiopharm Innovation Fund focuses on Biotech, Digital Health, Healthtech.
- Where is Debiopharm Innovation Fund located?
- Debiopharm Innovation Fund is headquartered in Lausanne, CH.
- Does Debiopharm Innovation Fund lead rounds?
- Yes, Debiopharm Innovation Fund leads investment rounds.
- Who does Debiopharm Innovation Fund co-invest with?
- Debiopharm Innovation Fund most often shares deals with Oncology Ventures, Newfund Capital, OrbiMed, among 48 tracked co-investors.
Media · Podcasts & interviews
featuring the teamFH23 - An interview with Marc Cikes, Managing Director Debiopharm, and Tom Gibbs, Investment Director Debiopharm Innovation Fund
Marc Cikes · vimeo.com
Debiopharm at AACR: First Clinical Data from the MYTHIC Trial (zedoresertib + lunresertib)
DebiopharmTV
Overcoming ADC Linker Challenges: The MultiLINK™ Technology Suite
DebiopharmTV
ADC Talks - Olivier Cochet
DebiopharmTV
ADC Talks - Sophie and Marianna
DebiopharmTV
Antoine’s Journey Finding Purpose at Debiopharm
DebiopharmTV
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Lightstone Ventures is a life sciences venture firm founded in 2012 that invests in biotech and medtech companies, backing founders translating scientific breakthroughs into therapies and medical technologies.